Health
5 Things to Watch in Higher Education, Contraceptives, Evidence-Based Policy, Organ Donation, and Democracy in 2022
Contraceptive Choice & Access
5 Things to Watch in Higher Education, Contraceptives, Evidence-Based Policy, Organ Donation, and Democracy in 2022
Look Ahead

5 Things to Watch in Health Care in 2022
Drug Prices
5 Things to Watch in Health Care in 2022
Look Ahead

Fallout From Controversial Alzheimer's Drug Continues
Drug Prices
Fallout From Controversial Alzheimer’s Drug Continues

Findings About the Dual-Eligible Consumer Experience
Complex Care
Findings About the Dual-Eligible Consumer Experience

5 Big Wins in 2021 for Higher Education, Democracy, Climate, Contraceptives, and Evidence-Based Policy
Contraceptive Choice & Access
5 Big Wins in 2021 for Higher Education, Democracy, Climate, Contraceptives, and Evidence-Based Policy
Year in Review

Congress: Pharma's Price Gouging is Purposeful
Drug Prices
Congress: Pharma’s Price Gouging is Purposeful

New Research Points to How to Reduce the $100 Billion Americans Spend Annually on Unnecessary Health Care
Provider Payment Incentives
New Research Points to How to Reduce the $100 Billion Americans Spend Annually on Unnecessary Health Care
Q&A

Video: Health Care is Not a Functioning Market
Commercial Sector Prices
Video: Health Care is Not a Functioning Market
Video Series: Health Care Prices
Complex Care
Fixing the FIDE-SNP — Redefining ‘Fully Integrated’

Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Drug Prices
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Complex Care
Improving Behavioral Health Supports for Dual-Eligible Individuals

Drug Pricing Reform Failure is Unacceptable
Drug Prices
Drug Pricing Reform Failure is Unacceptable
Op-Ed

HCBS Spending Plans and the Untapped Potential of D-SNPs
Complex Care
HCBS Spending Plans and the Untapped Potential of D‑SNPs

How Colorado Passed Sweeping Policies for Wider Contraceptive Choice
Contraceptive Choice & Access
How Colorado Passed Sweeping Policies for Wider Contraceptive Choice

Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Prices
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Affordability

Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Prices
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Affordability

Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Prices
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Affordability
Complex Care
New Resources Enable Investigators to Expand Research into Dual-Eligible Individuals

About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
-
Criminal Justice -
Evidence-Based Policy -
Contraceptive Choice & Access -
Research on Gun Violence -
Policing -
Complex Care -
Drug Prices -
Higher Education